http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009104629-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_50312cdc5abe7706ed3032d28d92d6fb
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2821
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
filingDate 2007-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c8a6a141be3e347d8435f295b8530ec
publicationDate 2009-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2009104629-A1
titleOfInvention Use of biomarkers of alzheimer's disease for diagnostic tests and drug screening
abstract The invention relates to method of diagnosing Alzheimer's disease or detecting a predisposition to Alzheimer's disease including providing a test cell sample from a subject, exposing the test cell sample to labeled amyloid beta peptides, and determining the level of labeled amyloid beta peptides in the test cell sample, wherein lower levels of labeled amyloid beta peptides in the test cell sample compared to a control cell sample are indicative of Alzheimer's disease.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017157961-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014242727-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10842871-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11340225-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012012257-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11655289-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9625459-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4063858-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9260473-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012012257-A3
priorityDate 2007-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID50990393
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406715
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46783367
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408029
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID352546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21292785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135728745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408119
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15764346
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280965
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57422521

Total number of triples: 48.